92P-10646-41214
4 vaccinations
4 coded responses
49 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 535 / WI
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
MUG-31278-47509
Child or adolescent in my care · Female · 2022-06-29
5WK-21673-59041
Child or adolescent in my care · Female · 2022-10-15
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Moderna
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-01
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Myalgia, Rash erythematous — Feeling: GoodFree text: Developed erythematous rash (about 8cm x 18 cm) and body aches on 1/2/21. Body aches resolved 1/4/21. Rash is still present but fadingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
-
2021-01-20
Dose 2 — Moderna
- 2021-01-20
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
-
2021-07-21
Survey response — 6 months, dose 2MedDRA: Hemiplegic migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased hemiplegic migrainesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Moderna
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Palpitations, Tachycardia — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Palpitations, tachycardiaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
-
2021-11-19
Survey response — day 14, dose 3MedDRA: Laryngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: LaryngitisMedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-12-03
- 2021-12-12
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-10-12
Dose 4 — Pfizer-BioNTech
- 2022-10-15
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2023-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-10-12 | Pfizer-BioNTech | No |
Free text
Release 1 — day 14, dose 1
Symptoms: Developed erythematous rash (about 8cm x 18 cm) and body aches on 1/2/21. Body aches resolved 1/4/21. Rash is still present but fading
Release 9 — 6 months, dose 2
Symptoms: Increased hemiplegic migraines
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Palpitations, tachycardia
Release 10 — day 14, dose 3
Symptoms: Laryngitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hemiplegic migraine | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | ○ | ○ | ○ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SRO | Palpitations | · | · | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release